FDA approves Rebif Rebidose(EMD Serono) for treatment of Multiple Sclerosis

The FDA has approved Rebif Rebidose, a single-use auto-injector prefilled with EMD Serono and Pfizer's interferon beta-1a, for the treatment of relapsing forms of Multiple Sclerosis (MS). Interferon beta-1a is an established and effective disease-modifying treatment for MS, but some people can struggle with injections, and the resulting drops in compliance mean the treatment is less effective.

A simple-to-use, single-use auto-injector as an alternative delivery option can make it easier for patients to self-administer the drug. EMD Serono is the U.S. subsidiary of Merck KGaA of Darmstadt, Germany.